Daily Round Up 4/18/16: OPK, PBIB, SVBI, FAV

by: InsiderInsights


Tables of the top insider purchases and sales filed with the SEC on 4/18/16, based on dollar value.

Dollar values often do not equate with significance when it comes to insider trades.

Proprietary Insider Company Ratings are relayed to clarify significance.

Dollar value is only one metric to assess the significance of an insider transaction, but when high dollar value intersects with significance it spotlights a stock investors should take the time to consider. InsiderInsights Daily Round Up articles are intended as initial research tools, so investors can separate real insider investment intelligence from time-wasting noise.

Click the Company Name links in the tables below to analyze a company's or insider's full insider history. Also feel free to email us with any questions on our proprietary insider data, Insider Filer Statistics, and Insider Company Ratings.

Educational note from InsiderInsights:
Insider filing volumes are at a seasonal low point due to companies closing trading windows to their insiders until quarterly earnings are released. As a result, the dollar values of trades featured in our Daily round Up articles (particularly the purchases) will likely be lower than usual until early May.

On Today's Tables:

Insider trades were rated Significant at :

  • Severn Bancorp (NASDAQ:SVBI);
  • Porter Bancorp (NASDAQ:PBIB);
  • Opko Health (NYSE:OPK), and;
  • First Trust Dividend & Income Fund (NYSE:FAV).

Insider trades were rated Nearly Significant at:

  • Summit Midstream (NYSE:SMLP);
  • Inovio Pharm (NASDAQ:INO), and;
  • Servicenow (NYSE:NOW).

Insider trades were considered Insignificant at:

  • Stryker (NYSE:SYK);
  • Liberty Interactive (NASDAQ:QVCA);
  • Neos Therapeutics (NASDAQ:NEOS);
  • Jazz Pharm (NASDAQ:JAZZ);
  • Ingersoll Rand (NYSE:IR);
  • Hemisphere Media (NASDAQ:HMTV);
  • Delta Air Lines (NYSE:DAL), and;
  • Axalta Coating Systems (NYSE:AXTA).

There is a Conflicted Insider Signal (both purchases & sales) at:

  • Urstadt Biddle (NYSE:UBA);
  • Ryman Hospitality (NYSE:RHP);
  • Monsanto (NYSE:MON);
  • Cbre (NYSE:CBG), and;
  • Akamai Tech (NASDAQ:AKAM).
Insider Purchases
#: Filer Name Insider Titles Company Name Ticker Trans
Dollar Value
1 Energy Capital II DIR,BO Summit Midstream SMLP AB $1,094,647
2 Leighton Thomson CEO,DIR Akamai Tech AKAM AB $999,778
3 Collins Morton DIR Inovio Pharm INO B $650,925
4 Bulldog Investors BO First Trust Div & Inc Fd FAV B $419,075
5 Reed Colin V CB,CEO Ryman Hospitality RHP B $388,694
6 Ray Bradford T DIR Porter Bancorp PBIB JB* $312,500
7 McMillan Charles S DIR Monsanto MON B $305,375
8 Hyatt Alan J CEO,DIR,BO Severn Bancorp SVBI B $110,000
9 Urstadt Charles J CB,DIR Urstadt Biddle UBA B $105,000
10 Frost Phillip Md CEO,CB,BO Opko Health OPK JB*,B $81,926

Source: | Key to Insider Title and Trans Type Codes :
B =Open-market Buy; AB=10b5-1 (automatic) Buy; JB*=Buy indicated as being open-market, but not confirmed by trading price range and volume for the session.

Insider Sales
#: Filer Name Insider Titles Company Name Ticker Trans
Dollar Value
1 Luddy Frederic B DIR Servicenow NOW AS $9,438,371
2 Anderson Richard CEO,DIR Delta Air Lines DAL S $5,867,691
3 Vadon Mark C DIR Liberty Interactive QVCA AS $5,658,352
4 Stryker Ronda E DIR Stryker SYK AS $1,314,085
5 Kramvis Andreas DIR Axalta Coating Systems AXTA AS $963,000
6 Groch James R CFO Cbre CBG AS $900,000
7 Wilson Karen J VP,FO Jazz Pharm JAZZ AS $751,050
8 Fine Capital BO Hemisphere Media HMTV S $701,800
9 Teirlinck Didier P VP Ingersoll Rand IR AS $620,000
10 Presidio Partners 2007 BO Neos Therapeutics NEOS S $593,288 | Key to Insider Title and Trans Type Codes :
S =Open-market Sale; AS=10b5-1 (automatic) Sale; JS*=Sale indicated as being open-market, but not confirmed by trading price range and volume for the session.

If you're interested in the insider history of a stock not shown here, you can search by ticker.

Did you miss our Previous Daily Round Up?

Disclosure: I am/we are long OPK.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.